Quick10K

⚲

Malvern Bancorp

Filings

10-K	2020-09-30	Filed 2021-01-29
10-Q	2020-06-30	Filed 2020-08-10
10-Q	2020-03-31	Filed 2020-05-11
10-Q	2019-12-31	Filed 2020-02-10
10-K	2019-09-30	Filed 2019-12-16
10-Q	2019-06-30	Filed 2019-08-09
10-Q	2019-03-31	Filed 2019-05-09
10-Q	2018-12-31	Filed 2019-02-11
10-K	2018-09-30	Filed 2018-12-14
10-Q	2018-06-30	Filed 2018-08-09
10-Q	2018-03-31	Filed 2018-05-10
10-Q	2017-12-31	Filed 2018-02-09
10-K	2017-09-30	Filed 2017-12-29
10-Q	2017-06-30	Filed 2017-08-09
10-Q	2017-03-31	Filed 2017-05-10
10-Q	2016-12-31	Filed 2017-02-09
10-K	2016-09-30	Filed 2016-12-14
10-Q	2016-06-30	Filed 2016-08-09
10-Q	2016-03-31	Filed 2016-05-10
10-Q	2015-12-31	Filed 2016-02-09
10-K	2015-09-30	Filed 2015-12-23
10-Q	2015-06-30	Filed 2015-08-13
10-Q	2015-03-31	Filed 2015-05-14
10-Q	2014-12-31	Filed 2015-02-13
10-K	2014-09-30	Filed 2014-12-18
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-13
10-Q	2013-12-31	Filed 2014-02-12
10-K	2013-09-30	Filed 2013-12-19
10-Q	2013-06-30	Filed 2013-08-13
10-Q	2013-03-31	Filed 2013-05-20
10-Q	2012-12-31	Filed 2013-02-12
10-K	2012-09-30	Filed 2012-12-26
10-Q	2012-06-30	Filed 2012-09-21

Reports

8-K	2020-11-09
8-K	2020-08-05
8-K	2020-05-06
8-K	2020-05-05
8-K	2020-02-28
8-K	2020-01-31
8-K	2019-11-01
8-K	2019-08-02
8-K	2019-05-01
8-K	2019-03-26
8-K	2019-03-14
8-K	2019-02-26
8-K	2019-01-31
8-K	2018-11-01
8-K	2018-10-09
8-K	2018-10-03
8-K	2018-10-01
8-K	2018-08-02
8-K	2018-07-09
8-K	2018-04-25
8-K	2018-02-22
8-K	2018-02-09
8-K	2018-01-31
8-K	2017-12-28

Malvern Bancorp Financials

MLVF Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	59	132	116	88	67	24	23	14	42	19	48	52	24	40	56	58	78	97	63	66	113	117	129	122	47	31	100	111	150	154
Accounts Receivable
Inventory
PP&E	8	16	8	7	7	16	7	7	7	16	7	7	7	16	6	6	7	17	7	7	7	19	7	7	7	18	7	7	7	18
Assets	652	712	688	684	666	602	594	585	578	542	603	631	624	656	727	764	796	821	879	962	1,011	1,046	1,057	1,083	1,054	1,034	1,128	1,210	1,266	1,265
Accounts Payable
Long-Term Debt
Liabilities	590	649	590	587	571	526	519	509	501	465	525	551	544	574	644	679	710	727	783	864	911	943	954	978	946	923	993	1,073	1,126	1,123
Stockholders' Equity	62	63	98	97	95	75	75	75	77	77	78	80	80	81	83	85	87	95	96	97	100	103	103	105	108	111	136	138	140	143


Income Statement ($MM)	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue																											1	0	0	0
Cost of Revenue
Gross Profit
R&D
SG&A
Tax					-0	7	0	0	0	0	0		0	0	0	0	0	-6	0	1	1	2	3	3	2	1	1	1	1	1
Net Income			1	-1	0	-19	0	-0	0	0	0	1	1	1	1	1	2	8	1	1	2	2	0	2	2	3	2	2	3	3


Cash Flow ($MM)	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating			-0	0		-25	-1	-1	1	0	-2	3	2	0	1	3	2	3	1	1	5		4	0	3	2	3	2	4	1
Cash Investing			7	-25		27	6	2	36	12	-28	-24	-23	-14	-55	-36	-13	0	-92	-80	-3		-1	-32	-45	2	-25	-70	-15	7
Cash Financing			-23	-3		-45	-7	-10	-8	-36	59	25	-6	30	70	35	31	16	57	81	45	-189	8	26	-32	-21	91	79	51	-5